Navigation Links
Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference
Date:9/18/2007

KENILWORTH, N.J., Sept. 18 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) will provide a live audio webcast of a presentation by Alex Kelly, vice president, Investor Relations, speaking about the company at the Merrill Lynch Global Pharmaceutical, Biotech and Medtech Conference in London on Sept. 19, 2007, at approximately 9 a.m. (London) (approximately 4 a.m. EDT).

Kelly will be speaking on the company's financial performance and the planned acquisition of Organon BioSciences N.V. (OBS). He may also reiterate the company's outlook, as previously stated in the company's second quarter 10-Q, on the following:

-- Sales of VYTORIN and ZETIA are expected to grow in 2007. However,

there is growing competition for Schering-Plough's key brands;

-- Gross margin for the full year of 2007 is expected to improve versus

2006, primarily as a result of annual cost savings of approximately

$100 million expected from the company's manufacturing streamlining

actions in 2006 and improved product mix. However, gross margin in the

second half of 2007 is expected to be slightly lower than the first

half due to the seasonality of some respiratory products;

-- As Schering-Plough's pipeline continues to progress, the company

expects that the number of patients in its clinical trials will

continue to increase in the remainder of 2007. R&D expenses, excluding

any upfront payments, are expected to continue to grow faster than

adjusted net sales in 2007. Adjusted net sales is defined as net sales

plus an assumed 50 percent of the global cholesterol joint venture net

sales;

-- The company's full-year 2007 tax rate is expected to be in the mid-

teens on a GAAP basis, but vary between quarters depending on the

product and country mix of earnings; and

-- In advance of the planned acquisition of OBS, the company will incur

integration planning-related costs and potential foreign currency-

related activity associated with the purchase. The transaction is

anticipated to be accretive to the company's earnings per share in the

first full year, excluding purchase-accounting adjustments and

acquisition-related costs. The company expects to achieve annual

synergies of $500 million, however, it is expected that it will take

three years from the closing to reach this level of synergies.

A live audio webcast of the presentation will be available by going to the Investor Relations section of the Schering-Plough corporate Web site, http://www.schering-plough.com, and clicking on the "Presentations/Webcasts" link. A replay of the webcast will be available later that day.

Schering-Plough is a global science-based health care company with leading prescription, consumer and animal health products. Through internal research and collaborations with partners, Schering-Plough discovers, develops, manufactures and markets advanced drug therapies to meet important medical needs. Schering-Plough's vision is to earn the trust of the physicians, patients and customers served by its approximately 33,500 people around the world. The company is based in Kenilworth, N.J., and its Web site is http://www.schering-plough.com.


'/>"/>
SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Sonic Foundry to Webcast Bridge Arch Floating Down Mississippi
2. New Sonic Foundry search engine finds words, phrases in video presentations
3. Sonic Foundry creates search engine for 7,000 expert video presentations
4. InvestMidWest calls for business presentations
5. BxVideo designs Web hosting service for Sonic Foundry media presentations
6. Distance Education Conference Selects Sonic Foundry to Make Keynotes, Panel Presentations Available On-Demand
7. Ethanol plant builder to expand Merrill facility
8. World Class Life Science and Pharmaceutical Companies Leverage DoveBid s Global Reach for Asset Management and Disposition
9. The state of global biotech: An Ernst & Young perspective
10. Doyle announces new energy, global warming policies
11. Lucigen Corp. enters global licensing agreement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/19/2017)... ... May 19, 2017 , ... ... Academic researchers with technologies ripe for commercialization, and who are affiliated with ... are encouraged to submit proposals. QED, now in its tenth round, is the ...
(Date:5/18/2017)... ... 18, 2017 , ... Lajollacooks4u has added another option for ... team-building package designed for groups of 10-30 people. Guests can choose their ... such as Blackened Shrimp with Edamame Salad, Pizza Rolls with Pepperoni and Mushrooms ...
(Date:5/18/2017)... ... ... NDA Partners Chairman Carl Peck, MD , announced today that Richard Kenley, ... Pharmaceutical Development Business Unit of Cardinal Health, has joined the firm as an Expert ... Chief Operating Officer at Anaborex, Senior VP and General Manager of the San Diego ...
(Date:5/18/2017)... ... May 17, 2017 , ... Cognition Corporation ... commercialization, has just released version 9.0 of the Cognition Cockpit platform. , “Our ... Cockpit,” says David Cronin, CEO of Cognition. “We’re thrilled to finally be able ...
Breaking Biology Technology:
(Date:4/11/2017)... Research and Markets has announced the addition of the "Global ... ... at a CAGR of 30.37% during the period 2017-2021. ... based on an in-depth market analysis with inputs from industry experts. ... the coming years. The report also includes a discussion of the ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
Breaking Biology News(10 mins):